Avatar
Deutsche Welle News source @dw.com · Bonn 🇩🇪· 5d

#Pharmaceuticals #GenericDrugs #Healthcare

Link Preview
www.dw.com
O que muda com o fim da patente do Ozempic no Brasil
Queda da patente abre caminho para que farmacêuticas brasileiras produzam canetas genéricas emagrecedoras mais baratas.
N
NewsMax News source @newsmax.com · West Palm Beach, Florida 🇺🇸· 1w

#WeightLoss #Pharmaceuticals #GenericDrugs

Link Preview
www.newsmax.com
Generic Ozempic to Soon Reach Billions of People
The Danish drug manufacturer Novo Nordisk is losing the patent for its popular weight loss drug semaglutide, sold as Wegovy for obesity and Ozempic for Type 2 diabetes.
Avatar
Hospital Review News source @beckershospitalreview.com · Jan 5

#GenericDrugs #AffordableHealthcare #Biosimilars

Link Preview
www.beckershospitalreview.com
Civica Rx's low-cost insulin, biosimilar launch in US
CivicaScript, a nonprofit generic drug company, has launched insulin glargine-yfgn and ustekinumab-aauz, expanding its national portfolio of low-cost treatments.
Avatar
Hospital Review News source @beckershospitalreview.com · Jan 5

#GenericDrugs #AffordableHealthcare #Biosimilars

Link Preview
www.beckershospitalreview.com
Civica Rx's low-cost insulin, biosimilar launch in US
CivicaScript, a nonprofit generic drug company, has launched insulin glargine-yfgn and ustekinumab-aauz, expanding its national portfolio of low-cost treatments.
Avatar
NASDAQ Stock Market News source @nasdaq.com · New York City 🇺🇸· Jan 5

#MultipleSclerosis #FDAApproval #GenericDrugs

Link Preview
www.nasdaq.com
ScinoPharm Wins First FDA Approval With Glatiramer Acetate Injection For Multiple Sclerosis
(RTTNews) - ScinoPharm Taiwan (TWSE: 1789) today announced that the U. S. FDA has approved its Glatiramer Acetate Injection, a generic version of Teva's Copaxone, for the treatment of adult patients with multiple sclerosis.
Avatar
NASDAQ Stock Market News source @nasdaq.com · New York City 🇺🇸· Jan 5

#MultipleSclerosis #FDAApproval #GenericDrugs

Link Preview
www.nasdaq.com
ScinoPharm Wins First FDA Approval With Glatiramer Acetate Injection For Multiple Sclerosis
(RTTNews) - ScinoPharm Taiwan (TWSE: 1789) today announced that the U.